Kyntra Bio, Inc.
KYNB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000921299
No open-market purchases or sales by Kyntra Bio, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $7.54M in total; no superinvestor holds it.
Superinvestors holding KYNB, Q2 2026
No superinvestor reported holding KYNB in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of KYNB each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q3 2021
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)